Photodynamic therapy (PDT) for mesothelioma patients got a boost when PHOTOFRIN obtained Orphan Drug Designation. PHOTOFRIN is often prescribed following surgery and chemotherapy for malignant mesothelioma cancer.
Related Post:
Drug Company Files for Orphan Drug Designation for Mesothelioma Treatment
Mesothelioma patients soon may have a new treatment option to consider for their rare and aggressive cancer. Pinnacle Biologics, Inc., an Illinois-based bio-pharmaceutical company, announced ...
Mesothelioma Treatment Combining Photodynamic Therapy Offers Hope to Patients
Attacking the lining that protects the vital organs of the body, mesothelioma is a rare and aggressive form of cancer that is diagnosed in 2,000 ...
Mesothelioma Study Exhibits Safe Treatment with Multimodality Approach
In a recently published study conducted by University of Pennsylvania researchers, Intensity Modulated Radiation Therapy (IMRT) in conjunction with surgery (extrapleural pneumonectomy) and intraoperative photodynamic ...
Mesothelioma Treatment Including Photodynamic Therapy Shows Promise in Recent Study
A study published in Seminars in Thoracic and Cardiovascular Surgery investigated the inclusion of photodynamic therapy in multimodality treatment for mesothelioma cancer. Malignant mesothelioma is ...
Mesothelioma Drug Alimta Helps Lung Cancer Patients
Eli Lilly and Company has recently received its fourth approval from the Food and Drug Administration (FDA) for its drug Alimta (pemetrexed), a chemotherapy drug ...
Tags: Asbestos, asbestos cancer articles, Clinical Trials, FDA, lung cancer, mesothelioma, mesothelioma and asbestos cancer, mesothelioma articles, mesothelioma cancer, research